TY - JOUR
T1 - Perioperative management of medications for psoriasis and psoriatic arthritis
T2 - A review for the dermasurgeon
AU - Hernandez, Claudia
AU - Emer, Jason
AU - Robinson, June K.
PY - 2008/4
Y1 - 2008/4
N2 - BACKGROUND: Psoriasis affects an estimated 3% of the world's population. Many are on chronic immunosuppressive therapy for the cutaneous and joint manifestations of this disorder. The management of these medications in the perioperative period is controversial. Psoriasis and psoriatic arthritis medications can affect wound healing, hemostasis, and infection risk during cutaneous surgery. OBJECTIVES: The objective of this article is to provide a critical review of various medications used for care of the psoriatic patient and their potential effect on cutaneous surgical procedures. CONCLUSIONS: This review summarizes current understanding of wound healing, hemostatic effects, and infectious risks regarding many psoriasis medications including nonsteroidal anti-inflammatory drugs, cyclooxygenase inhibitors, corticosteroids, various immunosuppressants, and biologic response modifiers. Recommendations vary depending on the agent in question, type of procedure, and comorbid conditions in the patient. Caution is advised when using many of the medications reviewed due to lack of human data of their effects in the perioperative period.
AB - BACKGROUND: Psoriasis affects an estimated 3% of the world's population. Many are on chronic immunosuppressive therapy for the cutaneous and joint manifestations of this disorder. The management of these medications in the perioperative period is controversial. Psoriasis and psoriatic arthritis medications can affect wound healing, hemostasis, and infection risk during cutaneous surgery. OBJECTIVES: The objective of this article is to provide a critical review of various medications used for care of the psoriatic patient and their potential effect on cutaneous surgical procedures. CONCLUSIONS: This review summarizes current understanding of wound healing, hemostatic effects, and infectious risks regarding many psoriasis medications including nonsteroidal anti-inflammatory drugs, cyclooxygenase inhibitors, corticosteroids, various immunosuppressants, and biologic response modifiers. Recommendations vary depending on the agent in question, type of procedure, and comorbid conditions in the patient. Caution is advised when using many of the medications reviewed due to lack of human data of their effects in the perioperative period.
UR - http://www.scopus.com/inward/record.url?scp=41149176165&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=41149176165&partnerID=8YFLogxK
U2 - 10.1111/j.1524-4725.2007.34091.x
DO - 10.1111/j.1524-4725.2007.34091.x
M3 - Review article
C2 - 18248470
AN - SCOPUS:41149176165
SN - 1076-0512
VL - 34
SP - 446
EP - 459
JO - Dermatologic Surgery
JF - Dermatologic Surgery
IS - 4
ER -